NLARx Newsletter Header
NLARx News
Election Day Edition, November 4, 2008
In This Issue
Campaign 2008
In the States
Outrage of the Week
Prices & Access
Advertising & Marketing
Fraud & Abuse
Pharma Watch
Medicare
Medicaid
Patents & Generics
Privacy
Reimportation
Safety and Clinical Trials
Fellowships
Quick Links
Join Our Mailing List
Campaign 2008
Would an Obama Victory Preempt Wyeth v. Levine? More
Drug Industry Helps Fund Controversial anti-Obama Ad More
In the States
STATES IN ACTION: Innovations in Health Policy, October/November 2008 More
KANSAS: State Sues 13 Drugmakers Over Medicaid Fraud More
ILLINOIS: Cook County Offering Prescription Drugs to Uninsured More
DC: NLARx Chair, Councilmember Catania Says Delay of Low-Income Health Program Needed in Financial Crisis More
MASSACHUSETTS: State's Largest Insurer To Require Adoption of E-Prescribing For Physicians More
CALIFORNIA: State to End Medicare Part B Premium Payments for Some Dual Eligibles More
MISSOURI: Record $31 Million Settlement Obtained from Schering-Plough More
Outrage of the Week
Women Buying Health Policies Pay Penalty More

Prices and Access to Healthcare
Medicare Pricing for Drugs Is Arcane More
New Report Reveals Huge Increases in Cost of Specialty Drugs More
Prescription Drugs Cost More in Poor Areas More
Pharmacies in Low-Income Areas of Florida Charge More Than Those in Higher-Income Areas More
Spending on Diabetes Drugs Nearly Doubles Over Six Years to $12.5B More

Advertising and Marketing
How Drug Companies Covertly Promote Off-Label Drug Use More
GlaxoSmithKline to Report Payments to Doctors More
Allergan Doesn't Comply with PhRMA Guidelines, Wins Kudos Anyway More
Pfizer Finalizes $60M Settlement With States Over Off-Label Marketing of COX-2 Inhibitors More
Free Samples: The Drug Rep's Last Great Hope More
State Medical Society Policy Bans All Gifts From Drug Companies More
J&J's Prevention Cure More
Alice, 35, is Not a Real Ambien CR Patient More

More Fraud and Abuse
Lilly Will Take $1.42 Billion Charge in Zyprexa Probe More

Pharma Watch
Pharma Top Industry in Slashing Jobs More
U.S. Drug Makers Face Mounting Problems More
Merck To Cut 7,200 Jobs, Close 3 Research Labs More
Drug Companies Indirectly Boosting Daniels' Campaign More
FDA Memos Undercuts Preemption Stance More
BIO Starts Web Site To Dispute CBS TV Show More
Cash-Poor Biotech Firms Cut Research, Seek Aid More
Outlook Is Cut For U.S. Drug Sales More
Editorial Says Big Pharma's Support For Democrats Could End Up Hurting Them in the Long Run More

Medicare 
Medicare Drug Plan Spending Drops $6B in 2008 More
Greater Generic Uptake Helps Push Medicaid Drug Spending Down $6 Billion More
Lack of Interest Derails Medicare B Drug Program More
Big Pharma Could Be Big Loser Under Obama Health Plan More
Humana's Profit Tumbled Nearly 40%, Dragged Down by Expected Decline in Premiums From Its Prescription Drug Plans More
Another Part C and Part D Annual Enrollment Period: Will Marketing Tactics Improve? More
Medicare Drug Plan Spending Drops $6B in 2008 More
Medicare Has Back Log of Drug-Plan Audits, Report Says More
Part D Nerds Celebrate Good Times More
Medicaid
CMS Behind in Medicare Pricing Audits That Help Prevent Pricing Fraud, GAO Finds More
Economists' Support Could Bode Well for Stimulus Plan With Medicaid Funds More
States Face Estimated Combined $100B Budget Gap by Fiscal Year 2010, Could Prompt Medicaid Cuts More

Patents and Generics
Insurers Entice Doctors to Prescribe Generic Drugs More
Doctors Get Meals And Money From Insurers More
CVS Slashes Generic Drug Costs, Escalates Price War More
Privacy
Caught Unaware, Doctors Get Delay in FTC Enforcement of ID Theft Rules More
Healthy Debate on Electronic Health Records More
Slow Adoption of e-Prescribing Forces Medicare to Try Hard Sell More
Trade and Reimportation
McCain, Obama Back Prescription Drug Importation But Acknowledge Safety Concerns, Advisers Say More
Safety and Clinical Trials
In Drug Case, Justices to Weigh Right to Sue More
NIH Reprimanded Employee For Flagging Conflicts of Interest More
Chantix Linked to Injuries in New Report
More
Pharma Funded Texas Clinical Trials Program, Despite Denials More
Cancer Drugs Used in Unapproved Ways as Much as 33% of the Time More
Pfizer's Zyvox Couldn't Halt Drug-Resistant Outbreak More
Beaches in U.S. Host Drug-Resistant Bacteria More
Doctors Prescribe Drugs for Placebo Effect More
Sales of Obesity Drug Acomplia Suspended in Europe More
Wyeth Loses Diet Pill Lawsuit Over Lung Ailment More
Bayer Aspirin With Supplements Is Illegal, U.S. Warns
More
Leading Medical Groups Advise Against Avandia More
Therapy, Drugs Ease Children's Anxiety More
Number of Kids on Medication Jumps Alarmingly More
Kids Swallow More Pills as Big Waistlines Become Growing Pain More
Supreme Court Weighs Drug Lawsuits More
Attorneys in Pre-Emption Case Seek To Add Documents Indicating Two FDA Officials Objected to Rules Aimed at Pre-Empting Lawsuits More
Preemption: The Business Case Of The Century More
The Safety Gap More

Fellowships
Application Available for 2009 Barbara Jordan Health Policy Scholars Program More